Tsumura & Co banner

Tsumura & Co
TSE:4540

Watchlist Manager
Tsumura & Co Logo
Tsumura & Co
TSE:4540
Watchlist
Price: 3 700 JPY 0.22% Market Closed
Market Cap: ¥284B

P/OCF

17.9
Current
7%
More Expensive
vs 3-y average of 16.8

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
17.9
=
Market Cap
¥304.1B
/
Operating Cash Flow
¥15.4B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
17.9
=
Market Cap
¥304.1B
/
Operating Cash Flow
¥15.4B

Valuation Scenarios

Tsumura & Co is trading above its 3-year average

If P/OCF returns to its 3-Year Average (16.8), the stock would be worth ¥3 462.54 (6% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-36%
Maximum Upside
No Upside Scenarios
Average Downside
23%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 17.9 ¥3 700
0%
3-Year Average 16.8 ¥3 462.54
-6%
5-Year Average 13.6 ¥2 814.28
-24%
Industry Average 13.5 ¥2 778.72
-25%
Country Average 11.5 ¥2 365.78
-36%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close

Market Distribution

Higher than 74% of companies in Japan
Percentile
74th
Based on 4 634 companies
74th percentile
17.9
Low
0.1 — 8
Typical Range
8 — 16
High
16 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 8
Median 11.5
70th Percentile 16
Max 277 515 329.3

Tsumura & Co
Glance View

Market Cap
284B JPY
Industry
Pharmaceuticals

Tsumura & Co., a venerable name in the herbal medicine industry, traces its roots back to 1893. Emerging from Japan's rich pharmacopeia tradition, the company has carved a niche by blending age-old herbal knowledge with contemporary research and quality control. This synergy allows Tsumura to thrive in the modern marketplace, offering Kampo—a traditional Japanese herbal medicine—as their primary product line. Tsumura stands out in its meticulous approach to sourcing high-quality raw materials, employing state-of-the-art technology to ensure efficacy and safety. This rigorous quality assurance not only honors the integrity of traditional formulas but also aligns with the stringent standards of modern healthcare. In its pursuit of growth, Tsumura expertly navigates the delicate balance between tradition and innovation. The company generates revenue through the sale of its Kampo products, which are widely used in clinics and hospitals across Japan, reflecting a significant integration into the mainstream healthcare system. Additionally, Tsumura's strategic collaborations with pharmaceutical companies expand its reach into international markets. Through educational initiatives, they further advocate for the understanding and acceptance of herbal medicine globally. By continually investing in research and development, Tsumura aims to bolster their product offerings, ensuring that the ancient wisdom of Kampo remains relevant in today's fast-paced, health-conscious world.

Intrinsic Value
3 472.39 JPY
Overvaluation 6%
Intrinsic Value
Price ¥3 700
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett